Sana Biotechnology Inc. Common Stock (NASDAQ: SANA)
11 Days left to seek lead plaintiff status.
On March 21, 2025, Sana Biotechnology, Inc. was sued for violations of the federal securities laws in the United States District Court for the Western District of Washington on behalf of investors who purchased or otherwise acquired Sana securities between March 17, 2023 and November 4, 2024, both dates inclusive (the “Class Period”).